Literature DB >> 35405740

Examination of Genetic Susceptibility in Radiation-Associated Meningioma.

A Pemov1, J Kim1, K Jones2, A Vogt2, S Sadetzki3, D R Stewart1.   

Abstract

Previous epidemiological studies have demonstrated elevated susceptibility to ionizing radiation in some families, thus suggesting the presence of genetic components that conferred increased rate of radiation-associated meningioma (RAM). In this study, we exome-sequenced and investigated the segregation pattern of rare deleterious variants in 11 RAM pedigrees. In addition, we performed a rare-variant association analysis in 92 unrelated familial cases of RAM that were ancestry-matched with 88 meningioma-free controls. In the pedigree analysis, we found that each family carried mostly a unique set of rare deleterious variants. A follow-up pathway analysis of the union of the genes that segregated within each of the 11 pedigrees identified a single statistically significant (q value = 7.90E-04) "ECM receptor interaction" set. In the case-control association analysis, we observed no statistically significant variants or genes after multiple testing correction; however, examination of ontological categories of the genes that associated with RAM at nominal P values <0.01 identified biologically relevant pathways such as DNA repair, cell cycle and apoptosis. These results suggest that it is unlikely that a small number of highly penetrant genes are involved in the pathogenesis of RAM. Substantially larger studies are needed to identify genetic risk variants and genes in RAM. ©2022 by Radiation Research Society. All rights of reproduction in any form reserved.

Entities:  

Mesh:

Year:  2022        PMID: 35405740      PMCID: PMC9326809          DOI: 10.1667/RADE-21-00035.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   3.372


  33 in total

1.  REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants.

Authors:  Nilah M Ioannidis; Joseph H Rothstein; Vikas Pejaver; Sumit Middha; Shannon K McDonnell; Saurabh Baheti; Anthony Musolf; Qing Li; Emily Holzinger; Danielle Karyadi; Lisa A Cannon-Albright; Craig C Teerlink; Janet L Stanford; William B Isaacs; Jianfeng Xu; Kathleen A Cooney; Ethan M Lange; Johanna Schleutker; John D Carpten; Isaac J Powell; Olivier Cussenot; Geraldine Cancel-Tassin; Graham G Giles; Robert J MacInnis; Christiane Maier; Chih-Lin Hsieh; Fredrik Wiklund; William J Catalona; William D Foulkes; Diptasri Mandal; Rosalind A Eeles; Zsofia Kote-Jarai; Carlos D Bustamante; Daniel J Schaid; Trevor Hastie; Elaine A Ostrander; Joan E Bailey-Wilson; Predrag Radivojac; Stephen N Thibodeau; Alice S Whittemore; Weiva Sieh
Journal:  Am J Hum Genet       Date:  2016-09-22       Impact factor: 11.025

2.  Radiation-induced head and neck tumours.

Authors:  B Modan; D Baidatz; H Mart; R Steinitz; S G Levin
Journal:  Lancet       Date:  1974-02-23       Impact factor: 79.321

3.  InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines.

Authors:  Quan Li; Kai Wang
Journal:  Am J Hum Genet       Date:  2017-01-26       Impact factor: 11.025

4.  A novel adaptive method for the analysis of next-generation sequencing data to detect complex trait associations with rare variants due to gene main effects and interactions.

Authors:  Dajiang J Liu; Suzanne M Leal
Journal:  PLoS Genet       Date:  2010-10-14       Impact factor: 5.917

5.  Tumors of the brain and nervous system after radiotherapy in childhood.

Authors:  E Ron; B Modan; J D Boice; E Alfandary; M Stovall; A Chetrit; L Katz
Journal:  N Engl J Med       Date:  1988-10-20       Impact factor: 91.245

Review 6.  Health risks for ataxia-telangiectasia mutated heterozygotes: a systematic review, meta-analysis and evidence-based guideline.

Authors:  N J H van Os; N Roeleveld; C M R Weemaes; M C J Jongmans; G O Janssens; A M R Taylor; N Hoogerbrugge; M A A P Willemsen
Journal:  Clin Genet       Date:  2016-01-20       Impact factor: 4.438

7.  Loss of SUFU function in familial multiple meningioma.

Authors:  Mervi Aavikko; Song-Ping Li; Silva Saarinen; Pia Alhopuro; Eevi Kaasinen; Ekaterina Morgunova; Yilong Li; Kari Vesanen; Miriam J Smith; D Gareth R Evans; Minna Pöyhönen; Anne Kiuru; Anssi Auvinen; Lauri A Aaltonen; Jussi Taipale; Pia Vahteristo
Journal:  Am J Hum Genet       Date:  2012-09-07       Impact factor: 11.025

8.  Common variation at 10p12.31 near MLLT10 influences meningioma risk.

Authors:  Sara E Dobbins; Peter Broderick; Beatrice Melin; Maria Feychting; Christoffer Johansen; Ulrika Andersson; Thomas Brännström; Johannes Schramm; Bianca Olver; Amy Lloyd; Yussanne P Ma; Fay J Hosking; Stefan Lönn; Anders Ahlbom; Roger Henriksson; Minouk J Schoemaker; Sarah J Hepworth; Per Hoffmann; Thomas W Mühleisen; Markus M Nöthen; Susanne Moebus; Lewin Eisele; Michael Kosteljanetz; Kenneth Muir; Anthony Swerdlow; Matthias Simon; Richard S Houlston
Journal:  Nat Genet       Date:  2011-07-31       Impact factor: 38.330

Review 9.  A heritable form of SMARCE1-related meningiomas with important implications for follow-up and family screening.

Authors:  E H Gerkes; J M Fock; W F A den Dunnen; M J van Belzen; C A van der Lans; E W Hoving; I E Fakkert; M J Smith; D G Evans; M J W Olderode-Berends
Journal:  Neurogenetics       Date:  2016-01-23       Impact factor: 2.660

10.  Genome-wide association analysis identifies a meningioma risk locus at 11p15.5.

Authors:  Elizabeth B Claus; Alex J Cornish; Peter Broderick; Joellen M Schildkraut; Sara E Dobbins; Amy Holroyd; Lisa Calvocoressi; Lingeng Lu; Helen M Hansen; Ivan Smirnov; Kyle M Walsh; Johannes Schramm; Per Hoffmann; Markus M Nöthen; Karl-Heinz Jöckel; Anthony Swerdlow; Signe Benzon Larsen; Christoffer Johansen; Matthias Simon; Melissa Bondy; Margaret Wrensch; Richard S Houlston; Joseph L Wiemels
Journal:  Neuro Oncol       Date:  2018-10-09       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.